Periodic Reporting for period 1 - VesSenDrugDeliv (A versatile platform for the design of targeting drug delivery vesicles)

Even though great progress has been made in the understanding of fundamental cancer biology and cancer therapy, the translation from fundamental research to advances in clinic is yet to be better addressed. One of the major issues is to selectively deliver the therapeutic...